Raymond James & Associates Veru Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Veru Inc. stock. As of the latest transaction made, Raymond James & Associates holds 33,079 shares of VERU stock, worth $84,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,079

Previous 26,961 22.69%

Holding current value

$84,020

Previous $22,000 13.64%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$0.77 - $1.04 $4,710 - $6,362	6,118 Added 22.69%	33,079 $25,000
Q2 2024 Jul 19, 2024	BUY	$0.76 - $1.79 $20,490 - $48,260	26,961 New	26,961 $22,000
Q2 2022 Aug 12, 2022	BUY	$4.35 - $15.85 $47 - $174	11 Added 0.01%	85,111 $962,000
Q1 2022 May 11, 2022	BUY	$4.55 - $6.41 $18,200 - $25,640	4,000 Added 4.93%	85,100 $411,000
Q4 2021 Feb 08, 2022	BUY	$5.89 - $9.73 $5,890 - $9,730	1,000 Added 1.25%	81,100 $478,000

Q2 2021 Aug 11, 2021	SELL	$7.24 - $11.2 $88,523 - $136,942	-12,227 Reduced 13.24%	80,100 $646,000
Q1 2021 May 14, 2021	BUY	$8.05 - $20.78 $70,196 - $181,201	8,720 Added 10.43%	92,327 $995,000
Q4 2020 Feb 12, 2021	SELL	$2.36 - $9.99 $15,087 - $63,866	-6,393 Reduced 7.1%	83,607 $723,000
Q4 2019 Feb 12, 2020	SELL	$1.86 - $3.35 $139,500 - $251,250	-75,000 Reduced 45.45%	90,000 $302,000
Q2 2019 Aug 06, 2019	BUY	$1.26 - $2.14 $50,400 - $85,600	40,000 Added 32.0%	165,000 $351,000
Q1 2019 May 06, 2019	BUY	$1.2 - $1.59 $44,400 - $58,830	37,000 Added 42.05%	125,000 $183,000
Q4 2018 Feb 11, 2019	BUY	$1.21 - $1.54 $1,210 - $1,540	1,000 Added 1.15%	88,000 $123,000
Q3 2018 Nov 14, 2018	BUY	$1.38 - $2.27 $85,560 - $140,740	62,000 Added 248.0%	87,000 $124,000
Q2 2018 Aug 14, 2018	BUY	$1.64 - $2.29 $41,000 - $57,250	25,000 New	25,000 $51,000

Others Institutions Holding VERU

# of Institutions

Shares Held

Call Options Held

Put Options Held

32.7K

View Full List

About VERU INC.

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $204M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

More about VERU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Veru Inc. Transaction History